A study demonstrated that the chromatin remodeling factor ARID1B suppressed the Wnt-β-catenin pathway (which is described below) [40], and another study described that ARID2 downregulated the epithelial–mesenchymal transition (EMT) of HCC cells [41]. This evidence concerns the gene ARID2 and hepatocellular carcinoma.